HomeMy WebLinkAboutalameda-inmar-annual-report-for-2023-archiveInmar Rx Solutions,Inc.
Alameda County
Safe Drug Disposal Stewardship Program
2023 Annual Report
(1/1/2023 through 12/31/2023)
Submitted:3/1/2024
EXECUTIVE SUMMARY 01
PARTICIPATING PRODUCERS 01
COLLECTION EFFORTS AND WEIGHT 02
COLLECTION SYSTEM 02
TRANSPORTERS AND DISPOSAL FACILITIES 03
SAFETY OR SECURITY CONCERNS 04
EDUCATIONAL EFFORTS AND PUBLIC OUTREACH 04
STEWARDSHIP PLAN GOALS 05
APPENDICES 09
Appendix A -Participating Producers 10
Appendix B -Collection System 16
Appendix C -Disposal Facilities 21
Appendix D -Kiosk Signage,Mailer Instructions and
Educational/Outreach Materials 22
Appendix E -Inmar ’s Website 31
Appendix F -Outreach and Promotion Activities 36
I.Executive Summary
Ordinance Sec.6.53.080 -Executive Summary.The purpose of the Executive Summary is to provide a broad understanding of the Plan as a
whole and context for the data and information that will follow.This summary should include a brief description of collection and disposal
efforts during the reporting period.The executive summary should also include a description of proposals to improve collection efforts and
challenges encountered during the reporting period,and how they will be addressed.
Inmar Rx Solutions,Inc (“Inmar”)was approved to operate a Drug Stewardship Program (“Program”)on April 1,
2022 pursuant to the Alameda Safe Drug Disposal Ordinance located at Title 6 of the Alameda County Health and
Safety Code,Sections 6.53.010 through 6.53.120 (“Ordinance”)and the Alameda County Safe Drug Disposal
Regulations (“Regulations'').This Annual Report is for the period between January 1,2023 and December 31,
2023 (“Reporting Period”).All capitalized terminologies not defined in this summary are the same as those used in
Inmar ’s approved Drug Stewardship Plan (“Plan”)dated April 10,2020.
The following information contained within this Annual Report mirrors the requirements outlined in Section
6.53.080 of the Ordinance.
A.Collection and Disposal Efforts
During this Reporting Period,Inmar operated 15 Collection Points and 60 Standard Mail-Back
Envelope Distribution Sites totaling 75 locations.Inmar collected 52 Inner Liners from the 15
Collection Points equaling 1,580.50 pounds of Unwanted Products.Inmar collected a total of
118 Mailers from the Standard Mail-Back Envelope Distribution Sites totaling 47.40 pounds of
Unwanted Products.Additionally,Inmar participated in eight collection events which resulted in
the collection of 3,339.5 pounds of Unwanted Products.For the 2023 Reporting Period,4,967.40
pounds of Unwanted Products were collected via all collection methods.
B.Plan Changes
There were no plan changes during the Reporting Period.
C.Program Outlook
Inmar expects an increase in the number of Collection Points and amount of Unwanted Products
collected in 2024.To achieve this,Inmar plans to host one-day collection events in conjunction
with Alameda County Department of Environmental Health and Alameda County Department of
Environmental Health Household Hazardous Waste Division for the second year in a row.Inmar
is continuously seeking additional Collection Points for either Drop-Off Kiosks or Standard
Mail-Back Envelope Distribution Sites.
II.Participating Producers
Ordinance Sec.6.53.080(a)(1)-A list of Producers participating in the Product Stewardship Program
A list of participating Producers can be found in Appendix A.
1
III.Collection Efforts and Weight
Ordinance Sec.6.53.010(a)(2)-The amount,by weight,of Unwanted Products collected from Residential Generators collected at each
drop-off site and in the entire County of Alameda and,if applicable,the total amount by weight collected by a Mail-Back Program
Regulation Sec.15(C)(iv)-The report narrative shall include a brief description of the collection efforts over the past year.
Throughout the Reporting Period,Inmar collected Unwanted Products by means of Collection Points (Drop-Off
Kiosks)and Standard Mail-Back Envelope Distribution Sites as well by Mail-Back Services that could be
requested via the Program’s website or toll-free phone number which includes Standard Mail-Back Envelopes,
Inhaler Mail-Back Envelopes and Auto-Injector Mail-Back Packages.The below table represents the total weight
collected in pounds by each of these mentioned Collection Methods.
Total Unwanted Products Collected in the Reporting Period from all Collection Methods
IV.Collection System
Ordinance Sec.6.53.080(A)(3)-A description of the collection system,including the location of each collection site and,if applicable,locations
where envelopes for a Mail-Back Program are provided.
Regulation Sec.15(D)(ii)-For each Collection Point:(a)location,host site name,and address;(b)collected Unwanted Products by weight
over the past year;and (c)number of times Unwanted Products was picked up for transportation per location.
Regulation Sec.15(D)(iii)-For any mail-back program:(a)the number of mail-back containers distributed;(b)the number of mail-back
containers returned;and (c)collected Unwanted Products by weight
A.Collection Points
Technical specifications concerning Inmar ’s Collection System can be located in the approved Plan dated
March 4,2022.Table 1 in Appendix B lists the weight for each Collection Point and the corresponding
number of liners collected.Table 2 in Appendix B lists each of Inmar’s Collection Points in Alameda
County.The number of Inner Liners in the Column titled “Liners Collected”is indicative of the number of
times the Unwanted Products were picked up from each location.Appendix B Table 4 lists all of the one
day Collection Events with the corresponding location,number of Inner Liner collected,and amount of
Unwanted Product collected.
2
Type #Total Weight (pounds)
Drop-off Site Liners 52 1,580.50
Standard Mail-Back Envelope 118 47.40
Inhaler Mail-Back Envelope 0 0
Auto-injector Mail-Back Packages 0 0
Collection Events 8 3,339.50
Total Weight Collected (2023)4,967.40
B.Standard Mail-Back Envelope Distribution Sites
Table 3 in Appendix B lists each participating Standard Mail-Back Envelope Distribution Site.In the
Reporting Period,Inmar distributed 70 Standard Mail-Back Envelopes to Standard Mail-Back Envelope
Distribution Sites in addition to existing Mails That were distributed in previous Reporting Periods.
Inmar distributed the following from the Program website:
●7 requests resulting in the distribution of 13 Standard Mail-Back Envelopes;
●20 requests resulting in the distribution of 34 Auto-Injector Mail-Back Packages;
●1 request resulting in the distribution of 1 Inhaler Mail-Back Envelope.
Inmar collected a total of 47.4 pounds of weight from the 118 Standard Mail-Back Envelopes in the
Reporting Period.There were no Auto-Injector Mail-Back Packages or Inhaler Mail-Back Envelopes
returned during the Reporting Period.
V.Transporters and Disposal Facilities
Ordinance Sec.6.53.080(A)(4)-The name and location of disposal facilities at which Unwanted Products were disposed of and the weight of
Unwanted Products collected from Residential Generators disposed of at each facility
Regulation Sec.15(d)(iv)-For each Disposal Facility:(a)the facility name,address and telephone number;and (b)the total weight of
collected products at each facility
See Appendix C for the name and location of Disposal Facilities at which Unwanted Products were disposed of in
accordance with the approved Plan.
Due to the widespread incinerator backlog issues at hazardous waste disposal facilities,Inmar’s Service Provider
has been unable to ship Unwanted Products out for destruction and is storing packaged Containers in accordance
with applicable state and federal regulations.Inmar’s Service Provider was specifically granted an exception from
DEA to the 30 calendar days after receipt drug destruction requirements set forth in Title 21 C.F.R.§1317.15(d),
which Inmar provided and is still in effect.A copy of this email can be found in Appendix G DEA Exception Email.
The DEA did not define an end date to the exception but the Service Provider stays in regular contact with DEA
and keeps them updated on disposal activity as they work toward goals and the management of backlog issues.
During the Reporting Period,the Service Provider was also granted an exception from DEA to 21 CFR
1317.70(a).Specifically,the Service Provider asked for an exception to the requirement for an on-site method of
destruction by an authorized collector who has a mail-back program because the Service Provider became unable
to operate at their Agawam,Massachusetts facility.DEA granted the exception for a period of 24 months from
August 22,2022 and allowed for the destruction of returned Mailers to occur at any of five provided locations,two
of which are,according to DEA records,registered reverse distributors (Clean Harbors at Aragonite,Utah;and
Clean Harbors at El Dorado,Arkansas).A copy of this exception letter was provided last year as a separate
communication and is still current.A copy of this letter can be found as a separate attachment titled DEA
Response Letter.In the event that incinerator backlog issues continue past the current expiration date,Inmar will
provide an updated extension letter to the County before the current Exception Letter expires.Inmar is aware of
these issues and has discussed this with our Service Provider.Inmar will be provided a renewed DEA exception
3
letter upon receipt and will forward to the County once received.
VI.Safety or Security Concerns
Ordinance Sec.6.53.080.(a)(5):Whether policies and procedures for collecting,transporting,and disposing of Unwanted Products,as
established in the Plan,were followed during the reporting period and a description of any noncompliance
Ordinance 6.53.080.(a)(6):Whether any safety or security problems occurred during collection,transportation,or disposal of Unwanted
Products during the reporting period and,if so,what changes have or will be made to policies,procedures,or tracking mechanisms to alleviate
the problem and to improve safety and security.
Policies and Procedures for collecting,transporting and disposing of Unwanted Products,as established in the
Plan,were followed in the Reporting Period.There are no Safety or Security Concerns for the reporting period.
VII.Educational Efforts and Public Outreach
Ordinance Sec.6.53.080(a)(7)-A description of public education and outreach activities implemented during the reporting period,including
the methodology used to evaluate the outreach and Program activities;
A.Educational Materials
In accordance with Ordinance 6.53.070,Inmar provided easily-consumable educational materials
for distribution to Residential Generators,pharmacists,retailers of Covered Drugs,veterinarians,
veterinarian hospitals and health care practitioners upon request and at no charge.Education
materials included standardized disposal instructions for Collection Points and Mail-Back
Services,an educational brochure that includes safe disposal options,the dangers of improper
drug use and disposal,and other program information.Additionally,Inmar hosted a program
website and toll-free phone number.All materials are easily understandable with varying levels of
English proficiencies and leverage explanatory graphics to aid in understanding.Materials are
available in English,Spanish,Vietnamese,Chinese,and Tagalog (Filipino).
The materials promote safe storage,inform of the risks of disposing of Unwanted Products in
inappropriate waste streams (eg solid waste collection,sewer,or septic systems)and the risks of
Covered Drugs as it pertains to drug abuse and accidental poisoning.The materials provide
options on how to participate in the safe disposal of Unwanted Products and other Program
advocacy.
Please see Appendix D for example materials.
B.Outreach Activities
Inmar conducted the following outreach activities during the Reporting Period:
1.Radio
Inmar utilized Alameda County radio station KOIT 95.6 FM (“KOIT”)for the second year in a row
to provide information on safe drug disposal throughout the listening area.KOIT is consistently
one of the top stations in Alameda County and the Bay Area radio market.Messaging also ran
simulcast across streaming platforms.The radio ads commenced the week of October 23,2023,
4
and ran through February 11th,2024 for a total of 12 weeks (excluding Holidays).Inmar excluded
the weeks of Thanksgiving and Christmas due to changes in listener’s priorities and work
schedules.There were a total of 43 advertisements each week,and the ads were 15 seconds in
length for a total of 516 advertisements.Alameda County Radio utilized optimization tactics
throughout the campaign to deliver the advertisement during heavier listening times to garner
more impressions.Advertisements focused on providing education on safe drug disposal and
directed listeners to find more information on the Inmar website,www.safemedicinedrop.com.Ads
emphasized that safe drug disposal options are free to all residents of Alameda County.
Inmar has insight into the scope of the outreach program by identifying total impressions.During
the duration of the 12 week radio campaign,Inmar was able to reach approximately 12,206,400
listeners.The total number of impressions is calculated by determining the number of listeners for
each advertisement that was deployed.A copy of the advertisement in Figure 4 in Appendix F.
2.Newspaper
For the second year in a row,Inmar utilized the East Bay Times to deploy advertisements on safe
drug disposal.The messaging encouraged users to remove Unwanted Products from the home to
protect the environment and prevent drug abuse.The ad also promoted Inmar ’s website
www.safemedicinedrop.com to find local Collection Points.The ad was one eighth (⅛)of a page
and ran weekly on Sundays for 12 weeks.The first ad was deployed on October 29,2023 and the
last ad was deployed on February 4,2024.For the same reasons as the radio advertisement,the
newspaper did not feature the ad the weeks of Thanksgiving and Christmas.During the 12 week
newspaper campaign,Inmar was able to reach approximately 979,248 readers.Total views are
reported directly from the media outlet.The radio advertisement can be provided upon request by
the Department.
3.Digital Media -Programmatic
Programmatic Media provides targeted display ads on browser sites on internet capable devices
(smart phones,computers,tablets,etc.).Inmar ran ads across a prequalified list of over 200,000
domains including a variety of retail websites,Google,and Facebook.The programmatic targeted
ads ran for six weeks leading up to the DEA’s National Prescription Take Back Days starting April
1,2023 and October 10,2023.Impression metrics are reported directly from the individual
websites that the ads are placed on and are reported on a per campaign basis.See Appendix F
Table 1 lines titled “Programmatic Spring Campaign”and “Programmatic Fall Campaign”for
programmatic results.Examples of the Programmatic ads are in Figure 3.
4.Digital Media -Influencer Marketing and Social Media
Influencer marketing is a content creation tactic used to drive awareness and education to a
targeted audience through blogs and social media outlets.Influencers create authentic content
around their everyday lives and interests while weaving the story of prescription drug take-back
into their content.Influencer content is converted into paid ad units across social platforms and
then targeted to Residents across Alameda County.
5
Paid advertisements for influencer content were run on a variety of platforms including Google,
Instagram and Facebook and drove towards a specified impression goal.Inmar ran several social
media influencer campaigns concurrently with other traditional and digital media campaigns.
Inmar posted two social media posts per month per platform (Instagram,Twitter,and Facebook).
Influencer campaigns were deployed quarterly for a total of four influencer campaigns in 2023.
The four influencer campaigns in Alameda County garnered a total of 3,540,145 impressions
throughout the Reporting Period.Images used in the influencer campaigns are included in
Appendix F,Figure 1.The dates and results of each campaign are listed in Appendix F,Table 1
line items “Q1 Influencer Campaign”,“Q2 Influencer Campaign”,“Q3 Influencer Campaign”,and
“Q4 Influencer Campaign”.
VIII.Stewardship Plan Goals
Ordinance 6.53.080(a)(8):How the Product Stewardship Program complied with all other elements in the product stewardship Plan approved
by the Department,including its degree of success in meeting any performance goals set by the Department as part of its approval of the
Program.
Regulation Sec.15(c)(ii)-Reporting on Goals.The Report Narrative should include a summary of the Plan goals and the degree of success in
meeting those goals in the past year.The discussion should include a summary of the efforts to meet the goals,any difficulty in meeting the
goals,and if any goals have not been met,what effort will be made to achieve such goals in the next year.
Alameda County Safe Drug Disposal Regulations Section 15(c)(iii):Future Goals.The Report Narrative should include proposed goals to be
accomplished in the upcoming year.If the proposed goals differ from the original Plan goals,the Annual Report should include a discussion of
the reasons for the suggested change(s).
A.Program Collection Goals
Inmar met short-term collection goals outlined in the approved Plan by securing and placing
Kiosks spread geographically throughout the County.This was completed within the first 90 days
of implementation.
Inmar ’s long-term goal was to achieve 100 Kiosks jointly with other Program Operators within the
first 12 months of Program implementation.As of December 2023,Inmar has secured a total of
75 Collection Points,15 Kiosks and 60 Standard Mail-Back Envelope Distribution Sites.In
conjunction with the other Program Operator,there are well over 100 Collection Points throughout
the County.
Inmar continues to work toward increasing collection and meeting long-term goals by partnering
with Alameda County Household Hazardous Waste Division in 2024 to host collection events.
B.Program Promotion Goals
Inmar met short-term promotion goals by launching the program website
(www.safemedicinedrop.com)and toll-free phone number (1-888-371-0717)within the first 90
6
days of program operation.Educational materials were also developed and distributed to
Covered Entities and Authorized Collectors within the first 90 days.Additionally,Authorized
Collectors were provided Kiosk training materials and marketing materials that included a sample
press release,educational materials,promotional materials,and signage.
Inmar continues to meet Program promotion goals by having ongoing social media posts,
influencer posts,and radio and newspaper advertising.Social media posts consisted of two posts
per month per platform (Instagram,Twitter,and Facebook).The Posts were scheduled as follows:
●The first social influencer campaign was deployed from March 3,2023 through March 24,
2023 the second influencer campaign ran from April 25,2023 through May 16,2023
●The third influencer campaign was from August 7,2023 through August 28,2023
●the fourth influencer campaign was from October 11,2023 through November 8,2023
Inmar commenced the print ad marketing in October 2023,coinciding with the DEA’s Annual
Take-Back Day.There were 12 one-eighth of a page newspaper advertisements,one per week
on Sundays,for 12 weeks.Inmar ’s first newspaper advertisement was on Sunday,October 29th,
2023 and the last advertisement was on February 4,2024.Inmar elected to place advertisements
in the Sunday newspaper due to Sunday being the highest circulation of the week.As reported
from East BayTimes,there were a total of 979,248 impressions.This is based on the number of
newspapers circulated in Alameda County.
The radio advertisement was 15 seconds in length and began on October 23,2023 and ran
through February 11,2024.There were 43 radio advertisements per week,for a total of 516 total
advertisements over the 12 week campaign.As reported from KOIT-FM,there were
approximately 1,017,200 impressions per week,which resulted in 12,206,400 total impressions
throughout the duration of the 12 week campaign.On average,listeners heard the message 6.7
times during the campaign.Both advertisements ran for a total of 12 weeks (intentionally skipping
the weeks of Thanksgiving and Christmas).
Both radio and newspaper advertisements were deployed on-time.Inmar successfully met the
Program promotion goals set for the Reporting Period.All program promotion activities continue
each Program year.See Appendix F Table 1 for total outreach campaign results.
PROGRAM COLLECTION GOALS
GOAL STATUS
90 DAYS
Initiate Plan operation Completed
Increase Authorized Collection Points in the County Completed
12 MONTHS
7
Inmar’s goal is to achieve 100 Kiosks distributed jointly,in
combination with other Plan Owners,across the County to
provide equitable and reasonably convenient access to
Residents.
Completed jointly with other Program Operator.
Establish Mail-Back Programs and/or Take-Back Events in
areas that are underserved by Collection Points.
Completed
Provide and communicate systems for pharmacies to request
Mail-Back Envelopes.
Completed
PROGRAM PROMOTION GOALS
GOAL STATUS
90 DAYS
Website launch Completed
Covered entity educational materials Completed
Authorized Collector marketing support materials Completed
Direct mail communication &print ad marketing commences Completed
6 MONTHS
Website functionality updates:
o Return Envelope requests
o Educational materials uploaded
o Authorized Collector Kiosk maintenance resources and
requests
o Collection Point and Mail-Back Envelope Distribution Site list
updated (ongoing)
Completed
Initiate social influencer and targeted media outreach (1
influencer campaign and 2 promoted LifeInCheckTM posts per
month)
Completed
Television &radio campaigns initiated Completed
12 MONTHS
Website functionality updates:
o Translation into specified languages
o Collection Point and Mail-Back Envelope Distribution Site list
updated (ongoing)
Completed
Continue social influencer and targeted media outreach (1
influencer campaign and 2 promoted LifeInCheckTM posts per
month)
Completed
Continue television &Radio campaigns This continues annually.
18 MONTHS
Website functionality updates:
o Collection Point and Standard Mail-Back Envelope
Distribution Site list updated (ongoing)
In Process as new locations are acquired.
Continue social influencer and targeted media outreach (1
influencer campaign and 2 promoted LifeInCheckTM posts per
This continues annually.
8
month)
Direct mail and print ad marketing continues This continues annually.
Continue television &radio campaigns This continues annually.
9
APPENDICES
Appendix A -Participating Producers 10
Appendix B -Collection System 13
Appendix C -Disposal Facilities 16
Appendix D -Kiosk Signage,Mailer Instructions and
Educational/Outreach Materials 17
Appendix E -Inmar ’s Website 26
Appendix F -Outreach and Promotion Activities 31
10
Appendix A -Participating Producers
The following list of Producers participated in Inmar ’s Stewardship Plan during the Reporting Period.
*All addresses listed are mailing and physical addresses unless otherwise indicated
Producer Contact Name TItle Mailing Address Contact Information
AAA Pharmaceutical,
Inc.
Tejash Sheth Vice President 681 Main Street
Lumberton,NJ 08048
Email:tsheth@aaapharm.com
Phone:609-288-6060 x 202
Adare Pharmaceuticals Babu Lad Global Head of
Regulatory
Affairs/Executive
Director
1200 Lenox Drive,Suite 100,
Lawrenceville,NJ 08648
Email:Babu.Lad@adareps.com
Phone:609-376-1719
Advagen Pharma Ltd Narendra Borkar President 666 Plainsboro Rd,Suite 605,
Plainsboro,NJ 08536
Email:
Narendra.Borkar@advagenpharma.
com
Phone:609-269-8128
Alcon Vision,LLC Herman Blakley Director,Health
Safety Environment
6201 South Freeway,TA625,
Fort Worth,TX 76134
Email:herman.blakley@alcon.com
Phone:610-670-3824
Alexso,Inc.Farbod Melamed Pharmacist,
Regulatory
Compliance
2317 Cotner Ave,
Los Angeles,CA 90064
Email:Farbod@alexso.com
Phone:310-282-8086
Alkermes,Inc.Jim Delaney Senior Director,
National Channel
Accounts
852 Winter Street,
Waltham,Massachusetts 02451
Email:
James.Delaney@alkermes.com
Phone:516-826-1785
ANDA,Inc Emily Hall Sr Mgr,Regulatory
Compliance
2915 Weston Road,
Weston,FL 33331
Email:emily.hall@andanet.com
Phone:800-331-2632 Ext.74579
Anda Pharmaceuticals,
Inc
Emily Hall Sr Mgr,Regulatory
Compliance
8644 Polk Lane
Olive Branch,Mississippi 38654
Email:emily.hall@andanet.com
Phone:800-331-2632 Ext.74579
Apnar Pharma,LP Vandan Patel IT Manager 4820 Lanier Road,
Chino,CA 91710
Email:
vandan.patel@apnarpharma.com
Phone:844-283-9825
Archis Pharma,LLC Vivin Lukose Director 15 Corporate Place South,Suite
108 ,
Piscataway,NJ 08854
Email:
vmlukose@rkpharmainc.com
Phone:732-640-4351
Ascend Laboratories Hindy Schiff Vice President
Regulatory
Affairs/Compliance
339 Jefferson Road,Suite 101,
Parsippany,NJ 07054 USA
Email:
HSchiff@ascendlaboratories.com
Phone:908.612.3079
ASO LLC Federico Juliao Sr.Director of
Regulatory Affairs
300 Sarasota Center Blvd,
Sarasota,FL 34240
Email:fjuliao@asocorp.com
Phone:941-379-0300
Bell Pharmaceuticals,
Inc
Betty Jo Lorenz VP,Quality &
Regulatory Affairs
200 W.Beaver St.
Belle Plaine,MN 56011
Email:Bettyjo@bellpharm.com
Phone:952-873-2288
Biocodex,Inc.Scott Koppang Senior Director,
Pharmaceutical
Affairs,Chief
Compliance Officer
1850 Gateway Drive,Suite 175
San Mateo,CA 94404
Email:s.koppang@biocodex.com
Phone:650-466-6935
Blairex Laboratories,Inc Jeff Legston President 1600 Brian Dr,
Columbus,IN 47201
Email:jlogston@blairex.com
Phone:812-378-1864
Camber Ron Cerminaro Director,1031 Centennial Ave.,Email:
11
Pharmaceuticals,Inc.Commercial
Strategy and
Operations
Piscataway,NJ 08854 rcerminaro@camberpharma.com
Phone:732.529.0430
Canton Laboratories,
LLC
Jack Melesh Director of Finance 1015 Nine North Dr,Suite 200,
Alpharetta,GA 30004
Email:jmelesh@cantonlabs.com
Phone:678-867-2900
Carlsbad Technology,
Inc
Sally Ver Vynck Account Executive 5922 Farnsworth Court,
Carlsbad,CA 92008
Email:
sally.vervynck@carlsbadtech.com
Phone:858-260-9198
Celltrion USA,Inc.Edwin Baras Director Head of
Supply Chain
One Evertrust Plaza,suite 1207,
Jersey City,NJ 07302
Email:Edwin.Baras@celltrion.com
Phone:201-600-9241
CivicaScript,LLC Michael Formica Principal,Business
Analytics and
Operations
2912 West Executive Parkway,
Suite 300,
Lehi,Utah 84043
Email:
michael.formica@civicascript.com
Phone:714-315-3038
Dr.Reddy's Laboratories
Inc.
Dr.Foram
Vaishnav
Sr.Director,Head -
Global PV Regions
and Risk
Management
107 College Road East,
Princeton,NJ 08540
Email:fvaishnav@drreddys.com
Phone:(609)375-9079
Duchesnay USA,Inc Gretchen
Schottin
Product Manager 2 Research Way,Suite 1A,
Princeton,NJ 08540
Email:
gschottin@duchesnayusa.com
Phone:610-937-4429
Epic Pharma,LLC June Zhang Director Operations 517 Rt 1 S,Ste 4002,
Iselin,NJ 08830
Email:june.zhang@puracap.com
Phone:732-789-3958
Florida Pharmaceutical
Products,LLC
Gina Campbell SVP Commercial
Operations
6111 Broken Sound Parkway NW,
Suite 160
Boca Raton,FL 33487
Email:
gcampbell@flpharmaproducts.com
Phone:561-609-3240
Formulation Technology,
Inc.
Marie Porter Director of
Operations
571 Armstrong Way,
Oakdale,CA 95361
Email:marie@formulationtech.com
Phone:209-847-0331
Fosun Pharma USA,Inc Huong Nguyen General Counsel 104 Carnegie Center Drive,Suite
204,
Princeton,NJ 08540
Email:
huong.nguyen@fosunpharmausa.c
om
Phone:408-200-9891
Genomma Lab USA,Inc Bradley N.
Johnson,Ph.D.
Director,US Quality
&Regulatory Affairs
3737 Buffalo Speedway,
Houston,TX 77098
Email:
johnson.bradley@genommalab.co
m
Phone:713-907-6570
Gensco Laboratories,
LLC
Paul M.
Zimmerman,MD
CEO 8550 NW 33rd St,Suite 200,
Doral,FL 33122
Email:info@genscolabs.com
Phone:855-743-6726
Granules
Pharmaceuticals,Inc.
Tanvi Mane Regulatory Affairs
Associate
3701 Concorde Parkway,
Chantilly,VA 20151
Email:
Tanvi.Mane@granulespharma.com
Phone:857 415 0784
Hetero Labs Limited Ron Cerminaro Director,
Commercial
Strategy and
Operations
1031 Centennial Ave.,
Piscataway,NJ 08854
Email:
rcerminaro@camberpharma.com
Phone:732.529.0430
Hikma Pharmaceuticals
USA Inc.
Heather S.
Patrick
Sr.Analyst,Legal
Affairs
200 Connell Drive,4th Floor,
Berkeley Heights,NJ 07922
Email:hpatrick@hikma.com
Phone:908.673.1030
i3 Pharmaceuticals,LLC Kartik Bhagat Director,Finance &
Operations Support
200 Park Avenue,
Warminster,PA 18974
Email:
kbhagat@i3pharmaceuticals.com
Phone:215-443-7000
Intercept
Pharmaceuticals,Inc.
Robert Satterfield Executive Director,
Quality Systems -
Process &
305 Madison Avenue,
Morristown,NJ 07960
Email:
bob.satterfield@interceptpharma.co
m
12
Compliance Phone:646-747-1000
KC Pharmaceuticals,
Inc.
Efren M.Haas Director of Quality 3215 Producer Way,
Pomona,CA 91768
Email:ehaas@kc-ph.com
Phone:909-598-9499 x 23
Lannett Company Inc.Michael
Gankiewicz
Director DEA &
Security
1101 C Avenue West,
Seymour,IN 47274
Email:mgankiewicz@lannett.com
Phone:215-333-9000
Laser Pharmaceuticals,
LLC
Jack Melesh Controller 1015 Nine North Drive,Suite 400,
Alpharetta,GA 30305
Email:
jmelesh@laserpharmaceuticals.co
m
Phone:770-754-9846
Leading Pharma,LLC Mark V.Chirico Senior Manager
Government
Reporting and
Contracts
3 Oak Rd,
Fairfield,NJ 07004
Email:
MCHIRICO@LEADINGPHARMA.C
OM
Phone:973-276-9600
LXO US Inc (formerly
Noden Pharma DAC)
Juliana Santos Supply Chain
Planner
D’Olier Chambers,16A D’Olier
Street,
Dublin 2,Republic of Ireland
Email:jsantos@nodenpharma.com
Phone:+353 1 912 15 88 x 588
Macleods Pharma Usa,
Inc
Jasleen Gupta Director PV/QA 103 College Road East,2nd Floor,
Princeton,NJ 08540
Email:
jasleeng@macleodspharma.com
Phone:609-269-5250
Marnel Pharmaceuticals,
LLC
Elizabeth
Shuttleworth
Director of
Operations
635 East Bay St,Bldg G,
Charleston,SC 29403
Email:
eshuttleworth@marnelpharmaceuti
cals.com
Phone:888-850-2905
McKeon Products,Inc.Tamara Peters Operations Manager 25460 Guenther,
Warren,MI 48091
Email:
tamara@macksearplugs.com
Phone:586-427-7200 ext 12
Medicure Pharma,Inc Leanne Taylor Compliance officer 116 Village Blvd.,Suite 200,
Princeton,New Jersey
Email:LTaylor@medicure.com
Phone:1-888-435-2220
Medsource
Pharmaceuticals
Raissa Bola Quality Control 22521 Avenida Empresa,Ste 109,
Rancho Santa Margarita,CA
92688
Email:
Orders@medsourcepharmaceutical
s.com
Phone:888-612-1965
Micro Labs USA,Inc Gaurang
Bhavsar,RAC
Associate Director -
Regulatory Affairs
220 Davidson Ave,Suite 402,
Somerset,NJ 08873
Email:
gaurangbhavsar@microlabs.in
Phone:908-484-7410
Mirum Pharmaceuticals Mark Jones Counsel 950 Tower Lane,Suite 1050,
Foster City,CA 94404
Email:mark.jones@mirumpharma.c
om
Phone:650-667-4085
Monarch PCM,LLC Sam Rizkal CEO/CFO 7333 Jack Newell Blvd,Suite 100,
Fort Worth,TX 76118
Email:samr@monarchpcm.com
Phone:682-708-6488 x 127
Navajo Manufacturing
Company Inc.
Felix Morales Quality Assurance
Manager
601 W 50th Ave,
Denver,CO 80216
Email:fmorales@navajoinc.com
Phone:303-292-3090 Ext 8265
Neogen Luke Brithinee Counsel -
Commercial &
Compliance
620 Lesher Place,
Lansing,MI 48912
Email:lbrithinee@neogen.com
Phone:313-670-8934
Neurelis,Inc Joe Duarte VP,Commercial
Operations
3430 Carmel Mountain Road,Suite
300,
San Diego,CA 92121
Email:jduarte@neurelis.com
Phone:858-251-2124
New American
Therapeutics,Inc
Phil Thompson Chief Operating
Officer and General
Counsel
300 Interpace Parkway,Morris
Corporate Center I,Building C3
Parsippany,NJ 07054
Email:
pthompson@newamericantx.com
Phone:314-326-6645
13
NextSource
Biotechnology
Thomas Hunter General Counsel,
Chief Compliance
Officer,Secretary
80 SW 8th Street,Suite 2660,
Miami,FL 33130
Email:tomhunter@trisourceph.com
Phone:855-672-2468
Nivagen
Pharmaceuticals
Genevieve
Stevens
Operations Director 3050 Fite Circle,Suite 100,
Sacramento,CA 95827
Email:gstevens@nivagen.com
Phone:916-364-1662
Novadoz
Pharmaceuticals,LLC
Sherice Koonce Senior Director,
Sales Operations
20 DUKE ROAD,SUITE A,
PISCATAWAY,NJ 08854-3714
Email:
sherice.k@novadozpharma.com
Phone:908-202-1854
Noven Pharmaceuticals,
Inc./Hisamitsu America,
Inc./Grove
Pharmaceuticals,a
division of Noven
Therapeutics,
LLC/Noven
Therapeutics,LLC
Marcos A.Ares Director Supply
Chain
11960 SW 144th St,
Miami FL 33186
Email:mares@noven.com
Phone:305-964-4556
Novugen Pharma (USA),
LLC
Michael Clark Senior Director,
Commercial
Operations,USA
100 Overlook Center,2nd Floor,
Princeton,NJ 08540
Email:michael.clark@novugen.com
Phone:732-857-7766
Oyster Point Pharma,
Inc.
Lawrence Levey Head of
Manufacturing and
Supply Chain
202 Carnegie Center,
Princeton,NJ 08540
Email:llevey@oysterpointrx.com
Phone:732-649-9022
ParaPRO,LLC Bill Culpepper President 11550 N Meridian St,Suite 290,
Carmel,IN 46032-5505
Email:billc@parapro.com
Phone:317.810.6201
Pharmacy Buying
Association,Inc
Nick Smock President,CEO 6300 Enterprise Rd,
Kansas City,MO 64120
Email:
Licensing.team@pbahealth.com
Phone:816-245-5700
PLX Opco Inc.DBA PLx
Pharma Inc.
Natasha
Giordano
CEO 9 Fishers Lane,
Sparta,NJ 07871
Email:NGiordano@plxpharma.com
Phone:973-219-1840
ProvePharm Tania Tardif Office Operations
Supervisor
100 Springhouse Drive Suite 105,
Collegeville,PA 19426
Email:
tania.tardif@provepharm.com
Phone:610-601-8600
Randob Labs,Ltd dba
CrossingWell Consumer
Health
Jessica Cole Executive Assistant Mailing Address:PO Box 440
Cornwall,NY 12518
Physical Address:45 Quaker Ave,
Suite 207,Cornwall,NY 12518
Email:jessica@randob.com
Phone:845-534-2197
RedHill Biopharma Inc.Michelle Dague Senior Director,
Compliance
8041 Arco Corporate Dr,Suite 200,
Raleigh,NC 27617
Email:mdague@redhillus.com
Phone:540-406-7460
Reliable 1 Laboratories,
LLC
David Seltzer CEO 99 West Hawthorne Ave,Suite
610,
Valley Stream,NY 11580
Email:
david.seltzer@reliable1labs.com
Phone:516-341-0666
S.S.S.Co.Lance Taylor Vice President of
Regulatory Affairs
71 University Ave,
Atlanta,GA 30315
Email:regulatory@ssscompany.net
Phone:404-521-0857 x 120
Sarepta Therapeutics Mercedes Forcier Associate Director,
Launch Readiness
Commercial
Operations
215 First St,Cambridge,MA
02142
Email:MForcier@Sarepta.com
Phone:617-710-3546
Sato Pharmaceutical
Co.,Ltd.
Bruce Takano General Manager 3625 Del Amo Blvd.Suite 228,
Torrance,CA 90503
Email:stakano@sato-pharmausa.co
m
Phone:310-787-1877
Scholl's Wellness
Company
Alex Terranova Director Quality &
Regulatory
119 Cherry Hill Road,Suite 200,
Parsippany,NJ 07054
Email:
alex.terranova@drscholls.com
Phone:862-328-1407
14
Sebela Pharmaceuticals
Inc.
Mike Beckelic Associate Director,
Quality Assurance &
Regulatory
Compliance
645 Hembree Parkway,Suite I,
Roswell,GA 30076
Email:
Mike.Beckelic@sebelapharma.com
Phone:678-736-5219
Sheffield
Pharmaceutical,LLC
Anthony Sollima CSO and EVP of
Regulatory Affairs
170 Broad Street,
New London,CT 06385
Email:
anthony.sollima@sheffieldpharma.c
om
Phone:860-442-4451 ext 2281
Socius Care,LLC Ben Ekwalla Managing Member 320 Northpoint Pkwy SE,Suite J,
Acworth,GA 30102
Email:bekwalla@sociuscare.com
Phone:404-566-8896 x 1100
SOLA Pharmaceuticals Tanna Varner Regulatory
Operations
Specialist
655 Highlandia Dr,
Baton Rouge,LA 70810
Email:tanna@solameds.us
Phone:866-747-7365
Solco Healthcare,LLC Julie Couturier OTC Manager 700 Atrium Dr,Suite A,
Somerset,NJ 08873
Email:
julie.couturier@solcohealthcare.co
m
Phone:855-581-9688
Somerset Pharma,LLC Arun Menon Chief Commercial
Officer
300 Franklin Square Dr,
Somerset,NJ 08873
Email:
arun.menon@somersetpharma.co
m
Phone:732-554-1100
Strides Pharma Inc.Michael Altamuro SVP,Sales &
Marketing (US)
1 Ram Ridge Rd,
Chestnut Ridge,NY 10977
Email:
mike.altamuro@stridesusa.com
Phone:845-682-3251
Summers Laboratories,
Inc.
Linda Czeiner General Manager 103 GP Clement Drive,
Collegeville PA 19426
Email:lindac@sumlab.com
Phone:877-902-3490
Sun (Taro)
Pharmaceutical
Industries,Inc.
Rick Lewellyn Assoc.Dir.Supply
Chain
2 Independence Way,
Princeton,NJ 08540
Email:Richard.lewellyn@taro.com
Phone 914-345-9001
Taro Pharmaceuticals
U.S.A.,Inc.
Rick Lewellyn Assoc.Dir.Supply
Chain
3 Skyline Dr,Suite 120,
Hawthorne,NY 10532
Email:Richard.lewellyn@taro.com
Phone:914-345-9001
The Tetra Corporation George A.Cioe President &CEO P.O.Box 10,
Eaton Rapids,MI 48827
Email:gcioe@TheTetraCorp.com
Phone:401-529-130
Time-Cap Laboratories,
Inc.
James Carroll Division Chief
Financial Officer
7 Michael Ave,
Farmingdale,NY 11735
Email:jcarroll@timecaplabs.com
Phone:631-753-9090
TruPharma,LLC John E.Mooney President 4100 W Kennedy Blvd,Suite 220,
Tampa,FL 33609
Email:jmooney@trupharma.com
Phone:312-953-2600
TWi Pharmaceuticals
USA,Inc.
Rick Pallokat President 115 West Century Road,Suite 135,
Paramus,NJ 07652
Email:
rick.pallokat@twipharmausa.com
Phone:201-762-1401
Unichem
Pharmaceuticals (USA),
INC.
Kartik M.
Keertikar
Senior Manager,
Regulatory Affairs
One Tower Center Boulevard,
Suite 2200,
East Brunswick,NJ 08816
Email:
kkeertikar@unichemusa.com
Phone:732-253-5954
United Exchange Corp Paul Kim Regulatory Affairs
Specialist
5836 Corporate Ave.Suite 200
Cypress CA 90630
Email:paul@ueccorp.com
Phone:562-977-4500
Upsher-Smith
Laboratories,LLC
Jennifer Graham Corporate Paralegal
-Compliance
Specialist
6701 Evenstad Drive,
Maple Grove,MN 55369
Email:
Jennifer.Graham@upsher-smith.co
m
Phone:763-315-2000
Veridian Healthcare LLC Steve Bisulca President 1175 Lakeside Dr,
Gurnee,IL 60031
Email:
sbisulca@veridianhealthcare.com
Phone:847-505-1902
15
Westminster
Pharmaceuticals,LLC
Adrienne Fink Financial Controller 3450 Buschwood Park Dr,Suite
110,
Tampa,FL 33618
Email:finance@wprx.com
Phone:727-300-1376
16
Appendix B:Collection System
Table 1-Weight Collected
Note:The number of liners in the Column titled “Liners Collected”is indicative of the number of times the product
was picked up from each location.A key in the form of a protected document will be accompanied with the
Annual Report for the County’s review.
Unique Identifier District Status Liners Collected Weight Collected (lbs)
63568 2 Active 0 0
49738 2 Active 0 0
62471 1 Active 2 54.5
62379 3 Active 2 56.85
62464 2 Active 2 59.65
62113 2 Active 3 82.9
62341 4 Active 4 88.5
42304 5 Active 4 96.6
62344 5 Active 4 109.3
62319 3 Active 4 140.9
62118 1 Active 5 145
62198 1 Active 5 169.5
62366 5 Active 6 179.35
62457 3 Active 3 190
62419 5 Active 8 207.45
52.00 1,580.50
17
Table 2 -Collection Points
Pharmacy Name /Dba Name Street City Zip Status
TIB Pharmacy 7999 Gateway Blvd.,Suite 110 Newark 94560 Active
RUUS VILLA ICF 29255 Ruus Rd Hayward 94544 Active
SAFEWAY PHARMACY #0993 3902 Washington Blvd Fremont 94538 Active
SAFEWAY PHARMACY #3281 2600 5Th St.Alameda 94501 Active
SAFEWAY PHARMACY #0971 22280 Foothill Boulevard Hayward 94541 Active
SAFEWAY PHARMACY #1197 1790 Decoto Road Union City 94587 Active
SAFEWAY PHARMACY #2856 6790 Bernal Ave Pleasanton 94566 Active
University of California at Berkeley 222 Bancroft Way Berkeley 94720 Active
SAFEWAY PHARMACY #2870 6310 College Ave Oakland 94618 Active
SAFEWAY PHARMACY #2708 2227 South Shore Center Alameda 94501 Active
SAFEWAY PHARMACY #1257 4495 First St Livermore 94551 Active
SAFEWAY PHARMACY #1931 46848 Mission Blvd Fremont 94539 Active
SAFEWAY PHARMACY #3132 5100 Broadway Oakland 94611 Active
SAFEWAY PHARMACY #0951 867 Island Drive Alameda 94502 Active
SAFEWAY PHARMACY #0691 1444 Shattuck Place Berkeley 94709 Active
18
Table 3 -Standard Mail-Back Envelope Distribution Sites
Site Name Street City Zip District
Safeway-1953 7499 Dublin Blvd Dublin 94568 1
Lucky-721 2000 Portola Ave Livermore 94550 1
Haller's LTC Pharmacy 4067 Peralta Boulevard Fremont 94536 1
Lifescript Pharmacy 39039 Paseo Padre Parkway Suite 201 Fremont 94538 1
Lucky California-750 2840 Dublin Blvd Dublin 94568 1
FoodMaxx -409 39441 Fremont Blvd Fremont 94538 1
Lucky-711 40055 Mission Blvd Fremont 94539 1
Safeway-1932 4440 Tassajara Rd Dublin 94568 1
Lucky-714 5000 Mowry Ave Fremont 94538 1
Lucky California-722 1951 Holmes St Livermore 94550 1
Haller's LTC Pharmacy 4067 Peralta Boulevard Fremont 94536 1
Costco Pharmacy #146 2800 Independence Drive Livermore 94550 1
Wild Smiles 4200 East Avenue Livermore 94550 1
Costco Pharmacy #778 43621 Pacific Commons Blvd Fremont 94538 2
Costco Pharmacy #1061 28505 Hesperian Blvd Hayward 94545 2
Costco Pharmacy #1660 350 Newpark Mall Newark 46070 2
FoodMaxx 416 699 Lewelling Blvd San Leandro 94579 2
FoodMaxx -462 39966 Cedar Blvd Newark 94560 2
Lucky California-716 25151 Santa Clara St Hayward 94544 2
FoodMaxx -406 27300 Hesperian Blvd Hayward 94545 2
Lucky-715 22555 Mission Blvd Hayward 94541 2
FoodMaxx -463 30073 Industrial Parkway SW Union City 94587 2
Lucky-782 32300 Dyer St Union City 94587 2
Lucky-712 34101 Fremont Blvd Fremont 94555 2
Lucky California-713 35820 Fremont Blvd Fremont 94536 2
Costco Pharmacy #118 1900 Davis St.San Leandro 94577 3
Lucky California-768 15840 Hesperian Blvd San Lorenzo 94580 3
MEDICAL ARTS PHARMACY 13847 East 14TH St Ste 103 San Leandro 94578 3
Lucky California-767 1300 Fairmont Dr San Leandro 94578 3
Lucky-736 247 E 18TH St Oakland 94606 3
FoodMaxx -484 3000 East 9TH ST Oakland 94606 3
Lucky California-700 815 Marina Village Parkway Alameda 94501 3
FoodMaxx -416 699 Lewelling Blvd San Leandro 94579 3
19
Specialty Mental Health -Oakland 310 8th Street,Suite 210 Oakland 94607 3
New Chinatown Pharmacy 719 East 12th Street Oakland 94606 3
Specialty Mental Health -San
Leandro 433 Callan Avenue,Suite 301 San Leandro 94577 3
Sutter Care at Home -Hospice 1025 Atlantic Avenue,Suite 350B Alameda 94501 3
California Sinus Center 5924 Soneridge Drive Suite 207 Pleasanton 94588 4
Safeway-908 3550 Fruitvale Ave Oakland 94602 4
FoodMaxx -417 10950 International Blvd Oakland 94603 4
Lucky California-734 1963 Mountain Blvd Oakland 94611 4
Safeway-768 20629 Redwood Rd Castro Valley 94546 4
Lucky-744 6155 W Las Positas Pleasanton 94566 4
Healthflex Home Health &Hospice 7677Oakport Dr.Oakland 94621 4
Lucky-704 3443 Castro Valley Blvd Castro Valley 94546 4
Raley's Pharmacy #316 5420 Sunol Blvd.Pleasanton 94566 4
Prescript Pharmaceuticals 39 California Avenue Pleasanton 94566 4
Crossroads Home Health -Oakland 333 Hegnberger Road,Suite 710 Oakland 94621 4
Lifelong Medical Care 2031 6th Street Berkeley 94710 5
Bonita House Inc.6333 Telegraph Avenue,Suite 102 Oakland 94609 5
Alta Bates Outpatient Pharmacy 2001 Dwight Way Berkeley 947042608 5
Safeway-676 1500 Solano Ave Albany 94706 5
Pak 'N Save-3125 3889 San Pablo Ave Emeryville 94608 5
Mindful Health Solutions -Oakland 3300 Webster Street,Suite 402 Oakland 94609 5
Home Care Assistance -Oakland 5275 Broadway Oakland 94618 5
Alegre Home Care -East Bay 5767 Broadway,Suite 201 Oakland 94618 5
Aids Healthcare Foundation -
Oakland 400 30th Street,Suite 300 Oakland 94609 5
Albany Police Department 1000 San Pablo Ave Albany 94706 5
Albany Police Department 1000 San Pablo Avenue Albany 94706 5
20
Table 4 -One-Day Drop Off Events
Date Location Time
Liners
Collected Pounds Collected
May 21,2023
Pleasanton County Fairgrounds
4501 Pleasanton Ave,Pleasanton CA 94566 9:00 AM -1:00 PM 11 551
June 25,2023
Golden Gate Fields
1100 Eastshore Highway,Albany CA 94710 9:00 AM -1:00 PM 9 462
July 9,2023
Coliseum A Lot
7000 Coliseum Way,Oakland CA 94621 9:00 AM -1:00 PM 7 345
July 22,2023
Canyon Middle School
19600 Cull Canyon Rd,Castro Valley CA 94552 8:00 AM -2:00 PM 8 456
September 10,2023
BART Parking Lot 1
1100 Decoto Rd,Union City CA 94587 9:00 AM -1:00 PM 8 420
September 24,2023
Golden Gate Fields
1100 Eastshore Highway,Albany CA 94710 9:00 AM -1:00 PM 7 418
October 15,2023
Coliseum North Lot
7000 Coliseum Way,Oakland CA 94621 9:00 AM -1:00 PM 5 225
November 12,2023
Spirits Alley
W Tower Ave and Monarch St,Alameda CA
94501 9:00 AM -1:00 PM 8 463
TOTAL 63 3,339.50
21
Appendix C:Disposal Facilities
Company Name
Contact
Information Registration Information Service Provided
Weight
Disposed (Lbs)
123 Compliant Logistics,LLC
2626 N 29th Ave
Phoenix,AZ 85009
Operations
Manager
602-612-4140
DEA Reverse Distributor-
Collector:
R90571264
DEA Reverse
Distributor-Kiosk
Liners N/A
Clean Harbors Aragonite
11600N.Aptus Rd.
Aragonite,UT94029
Operations
Manager
435-884-8100
EPA ID:
UTD981552177
Hazardous Waste
Incinerator -
All Unwanted Covered
Drugs
0
Clean Harbors El Dorado,LLC
309 American Circle
El Dorado,AR 71730
Operations
Manager
870-863-7173
EPA ID:
ARD069748192
Hazardous Waste
Incinerator -
All Unwanted Covered
Drugs 0
Veolia ES Technical Solutions,
L.L.C
7665 Highway 73
Port Arthur,TX 77640
Operations
Manager
281-216-9618
EPA ID:
TXD000838896
Hazardous Waste
Incinerator -All Unwanted
Covered Drugs 0
*Note:Due to the ongoing hazardous waste backlog issue affecting the country,the destroyed weights outlined here have been collected and
held prior to destruction.Inmar collected a total of 4,967.4 pounds of unwanted medication,but is yet to be destroyed.
22
Appendix D -Kiosk Signage,Mailer Instructions and
Educational/Outreach Materials
Figure 1 -Sample Promotional Signage
23
Figure 2 -Sample Kiosk Signage -Front
Figure 3 -Sample Kiosk Signage -Chute Door
24
Figure 4 -Sample Signage and instructions for Standard Mail-Back Envelope Distribution Sites
25
Figure 5 -Educational Brochure -English
Figure 6 -Educational Brochure -Spanish
26
Figure 7 -Educational Brochure -Chinese
Figure 8 -Educational Brochure -Vietnamese
27
Figure 9 -Educational Brochure -Tagalog
28
Figure 10 -Sample Kiosk including Sample Signage
29
Figure 11 -Sample Standard Mail-Back Envelope Insert
Figure 12 -Sample Inhaler Envelope Insert
30
Figure 13 -Sample Auto-Injector Package Insert
31
Appendix E:Inmar ’s Website
Figure 1 -www.SafeMedicineDrop.com Landing Page
Figure 2 -www.SafeMedicineDrop.com Alameda County Landing Page
32
Figure 3 -www.safemedicinedrop.com Disposal Options Nearby -Alameda County
Figure 4 -www.safemedicinedrop.com Mail-Back Request -Alameda County
33
Figure 5 -Frequently Asked Questions (FAQ)Page on www.safemedicinedrop.com
34
Figure 6 -Contact Information on www.safemedicinedrop.com
35
Figure 7 -Educational Materials Location on www.safemedicinedrop.com
36
Appendix F -Outreach Activities and Promotions
Figure 1 -Images from Influencer Campaigns
37
Figure 2 -Newspaper Advertisement Featured in East Bay Times
38
Figure 3 -Examples of Programmatic Media
39
Table 1 -Results From All Outreach Activities During the Reporting Period
Outreach Activity Type of Media Start Date End Date Impressions Frequency
Q1 Influencer Campaign Digital Promotion 3/3/23 3/24/23 508,733 1
Q2 Influencer Campaign Digital Promotion 4/25/23 5/16/23 421,619 1
Q3 Influencer Campaign Digital Promotion 8/7/23 8/28/23 1,389,928 1
Q4 Influencer Campaign Digital Promotion 10/11/23 11/8/23 1,219,865 1
Social Media Posts -Instagram,Twitter,Facebook Digital Promotion 1/19/23 12/29/23 305 24
Programmatic Spring Campaign Digital Promotion 4/1/23 5/18/23 350,000*1
Programmatic Fall Campaign Digital Promotion 10/10/23 12/31/23 250,000*1
Newspaper Advertising Print Ads 10/29/2023 2/4/2023 979248*12
Radio Advertising Radio 10/23/23 2/11/24 12,206,400*516
*Asterisks represent an estimated number of impressions reported by the agency
40
Appendix G -DEA Exception Email
DEA Exception Email -Page 1
41
DEA Exception Email -Page 2
42